Chapman University, Irvine, California.
Sr Care Pharm. 2021 Nov 1;36(11):556-567. doi: 10.4140/TCP.n.2021.556.
To review current guidelines and literature regarding continuous glucose monitoring (CGM) use in the management of type 2 diabetes mellitus (T2DM) in older people. A PubMed search of articles published through August 2020 using a combination of the following: older people, T2DM, continuous glucose monitoring, hypoglycemia, and hyperglycemia. Relevant randomized control trials, meta-analyses, and guidelines were assessed for the use of CGM in older patients with T2DM. Articles were included based on relevance to the topic, detailed methods, and complete results. CGM use in T2DM management in older people is not well defined. CGM may be a valuable technology in older people who face unique challenges, such as hypoglycemia, decline in cognitive function, and variable glucose levels. This article provides a review of recommendations for glucose monitoring in T2DM and discusses the role of specific CGM products. CGM is a viable option for older people with T2DM to help improve overall diabetes control. Pharmacists can play an important role in educating patients about this technology.
回顾有关老年人 2 型糖尿病(T2DM)管理中连续血糖监测(CGM)使用的现行指南和文献。使用以下组合方式在 PubMed 上搜索了截至 2020 年 8 月发表的文章:老年人、T2DM、连续血糖监测、低血糖和高血糖。评估了针对老年 T2DM 患者使用 CGM 的随机对照试验、荟萃分析和指南。基于与主题的相关性、详细方法和完整结果选择了文章。CGM 在老年人 T2DM 管理中的使用尚未明确定义。CGM 可能对面临独特挑战(如低血糖、认知功能下降和血糖水平变化)的老年人来说是一种有价值的技术。本文回顾了 T2DM 血糖监测的建议,并讨论了特定 CGM 产品的作用。CGM 是 T2DM 老年患者的可行选择,有助于改善整体糖尿病控制。药剂师可以在向患者介绍这项技术方面发挥重要作用。